Featured Content

Managing Adverse Events in the Era of Immunotherapy

The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.

Emerging Therapies for Prostate Cancer

New diagnostic and therapeutic tools are in development to inform the management of advanced and metastatic disease.

Muscle-Invasive Bladder Cancer: The Evolving Treatment Landscape

Patients diagnosed with MIBC are at a significant risk for death — which has not greatly improved in the last few decades.

Multidisciplinary Models for Treating Renal Cell Carcinoma

A shift toward multidisciplinary care is inevitable for the treatment of locally advanced and metastatic RCC.

More Features>>>

Urologic Cancers Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs